SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (3981)6/3/2001 10:40:21 PM
From: Miljenko Zuanic  Respond to of 52153
 
Ops,

ATRX formulation. Already explained.



To: Biomaven who wrote (3981)6/12/2001 8:49:18 PM
From: Miljenko Zuanic  Respond to of 52153
 
<<Miljenko,
<<Aberelix>>

Well I hope you're wrong on this one, because I'm holding on for now. Certainly an allergic reaction to something in a depot formulation could potentially be a significant concern - no way to remove the allergen.>>

Seams that my gut filling was correct one. Nothing to be proud off. Also, until *inadequate* is spelled out in plain English I will stay aside.

Miljenko